Khurram Jamil

1.6k total citations · 1 hit paper
50 papers, 814 citations indexed

About

Khurram Jamil is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khurram Jamil has authored 50 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 27 papers in Epidemiology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khurram Jamil's work include Liver Disease and Transplantation (37 papers), Liver Disease Diagnosis and Treatment (25 papers) and Electrolyte and hormonal disorders (19 papers). Khurram Jamil is often cited by papers focused on Liver Disease and Transplantation (37 papers), Liver Disease Diagnosis and Treatment (25 papers) and Electrolyte and hormonal disorders (19 papers). Khurram Jamil collaborates with scholars based in United States, Canada and Ireland. Khurram Jamil's co-authors include S. Chris Pappas, Florence Wong, Arun J. Sanyal, Shannon Escalante, K. Rajender Reddy, Michael P. Curry, R. Todd Frederick, Stevan A. Gonzalez, Hugo E. Vargas and Thomas Boyer and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Khurram Jamil

42 papers receiving 800 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

2021 246 citations Florence Wong, S. Chris Pappas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khurram Jamil United States	13	590	382	339	190	130	50	814
L Guevara United States	6	319 0.5×	257 0.7×	221 0.7×	84 0.4×	42 0.3×	9	750
P Kirstetter France	12	360 0.6×	161 0.4×	214 0.6×	82 0.4×	49 0.4×	22	515
Júlio César Martins Monte Brazil	13	46 0.1×	84 0.2×	110 0.3×	65 0.3×	202 1.6×	30	717
Antonio De Vincentis Italy	18	164 0.3×	411 1.1×	178 0.5×	44 0.2×	9 0.1×	65	891
Z Ma Canada	10	671 1.1×	490 1.3×	249 0.7×	31 0.2×	114 0.9×	11	873
Vivian Tan Canada	11	161 0.3×	172 0.5×	112 0.3×	35 0.2×	57 0.4×	33	440
Daniela Patrono Italy	11	162 0.3×	220 0.6×	125 0.4×	39 0.2×	19 0.1×	30	536
Fernando Anaya Spain	13	82 0.1×	152 0.4×	117 0.3×	56 0.3×	84 0.6×	40	702
Steven D. Salhanick United States	13	70 0.1×	83 0.2×	106 0.3×	75 0.4×	16 0.1×	23	694
R.D. Hughes United Kingdom	11	175 0.3×	72 0.2×	134 0.4×	18 0.1×	17 0.1×	19	397

Countries citing papers authored by Khurram Jamil

Since Specialization

Citations

This map shows the geographic impact of Khurram Jamil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khurram Jamil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khurram Jamil more than expected).

Fields of papers citing papers by Khurram Jamil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khurram Jamil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khurram Jamil. The network helps show where Khurram Jamil may publish in the future.

Co-authorship network of co-authors of Khurram Jamil

This figure shows the co-authorship network connecting the top 25 collaborators of Khurram Jamil. A scholar is included among the top collaborators of Khurram Jamil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khurram Jamil. Khurram Jamil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockey, Don C., Fredric D. Gordon, Paul J. Thuluvath, et al.. (2025). Terlipressin for Hepatorenal Syndrome in Patients With Early‐Stage Acute‐on‐Chronic Liver Failure. Liver International. 45(12). e70399–e70399. 3 indexed citations

Cullaro, Giuseppe, Andrew S. Allegretti, Kavish R. Patidar, Khurram Jamil, & Juan Carlos Q. Velez. (2025). The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis. Hepatology. 83(1). 94–104. 1 indexed citations

Bajaj, Jasmohan S., et al.. (2025). Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies. Alimentary Pharmacology & Therapeutics. 62(11-12). 1192–1201.

Hurvitz, Noa, Heather K. Lehman, Khurram Jamil, et al.. (2025). A constrained disorder principle-based second-generation artificial intelligence digital medical cannabis system: A real-world data analysis. Journal of public health research. 14(2). 1224438696–1224438696. 2 indexed citations

Reddy, K. Rajender, Ethan M. Weinberg, Stevan A. Gonzalez, et al.. (2024). Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population. Liver Transplantation. 30(10). 1026–1038. 2 indexed citations

Weinberg, Ethan M., Florence Wong, Hugo E. Vargas, et al.. (2023). Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transplantation. 30(4). 347–355. 3 indexed citations

Curry, Michael P., Hugo E. Vargas, Alex S. Befeler, et al.. (2023). Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology Communications. 7(1). e1307–e1307. 22 indexed citations

Gelman, Ram, Noa Hurvitz, Dean Nachman, et al.. (2023). A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial. Biomedicine & Pharmacotherapy. 161. 114334–114334. 27 indexed citations

Weinberg, Ethan M., Stevan A. Gonzalez, Manhal Izzy, et al.. (2023). INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion. Contemporary Clinical Trials Communications. 36. 101211–101211. 1 indexed citations

10.

Reddy, K. Rajender, Ethan M. Weinberg, Stevan A. Gonzalez, et al.. (2023). Safety and efficacy of continuous infusion terlipressin in acute kidney injury-hepatorenal syndrome: the Infuse study. Journal of Hepatology. 78. S241–S241. 1 indexed citations

11.

Jamil, Khurram, et al.. (2022). The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records. Current Therapeutic Research. 96. 100663–100663. 3 indexed citations

12.

Jamil, Khurram, Ethan M. Weinberg, & K. Rajender Reddy. (2022). S1173 Terlipressin Treatment of Patients With Hepatorenal Syndrome Type 1 Decreased the Need for Renal Replacement Therapy in Transplant Recipients: A 12-Month Follow-Up of the CONFIRM Study. The American Journal of Gastroenterology. 117(10S). e853–e853. 1 indexed citations

13.

Berg, Marc, et al.. (2021). A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomedicine & Pharmacotherapy. 143. 112228–112228. 35 indexed citations

14.

Moore, Kevin, Khurram Jamil, Linlin Luo, et al.. (2020). Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Alimentary Pharmacology & Therapeutics. 52(2). 351–358. 23 indexed citations

15.

Jamil, Khurram, S. Chris Pappas, Florence Wong, & Arun J. Sanyal. (2019). Verified Hepatorenal Syndrome Reversal As A Robust Multi-Component Primary End Point: The CONFIRM Study Trial Design. Volume 11. 67–73. 2 indexed citations

16.

Jamil, Khurram, S. Chris Pappas, & Krishna Devarakonda. (2017). In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2. Journal of Experimental Pharmacology. Volume 10. 1–7. 38 indexed citations

17.

Rice, J. Bradford, Alan G. White, Kevin Korenblat, et al.. (2017). The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States. Current Medical Research and Opinion. 33(8). 1473–1480. 23 indexed citations

18.

Wong, Florence, S. Chris Pappas, Thomas Boyer, et al.. (2016). Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome. Clinical Gastroenterology and Hepatology. 15(2). 266–272.e1. 45 indexed citations

19.

Toombs, Christopher F., Michael A. Insko, Edward A. Wintner, et al.. (2010). Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. British Journal of Clinical Pharmacology. 69(6). 626–636. 106 indexed citations

20.

Jamil, Khurram, et al.. (2007). Acute liver failure in a patient with lung cancer. Gut. 56(9). 1190–1190. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact